In BC, ac4C mediated by NAT10 regulates the occurrence of resistance to chemotherapy and radiotherapy suggesting that the writer NAT10 is a potential therapeutic target for overcoming resistance to clinical treatment. This evidence concerns the gene NAT10 and breast cancer.